{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-002130","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2025-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.239585+00:00","generated_at":"2026-05-24T00:35:41.125238+00:00","sec_items":["5.08"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Bone Biologics sets 2025 annual meeting for May 30; shareholder proposals due April 11","bullets":["2025 Annual Meeting on May 30, 2025; record date and proposals to be detailed in proxy statement.","Deadline for shareholder proposals and director nominations is April 11, 2025 (ten calendar days after this filing).","Submit proposals to Bone Biologics Corporation, Attn: Corporate Secretary, 2 Burlington Woods Dr, Ste 100, Burlington, MA 01803."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-002130","json":"https://secwatch.observer/filing/0001641172-25-002130.json","markdown":"https://secwatch.observer/filing/0001641172-25-002130.md","text":"https://secwatch.observer/filing/0001641172-25-002130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225002130/0001641172-25-002130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225002130/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T00:35:41.125238+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}